Cofepris detects 7 new irregular drug distributors in the country

Irregular Drug Distributors

Cofepris, Mexico’s regulatory agency, has detected 7 new irregular medicine distributors in the country. The mission of the Federal Commission for Protection against Health Risks (Cofepris) is to safeguard the health of the population by preventing possible risks caused by irregular products that are marketed in establishments that do not comply with current regulations. Read more here

If you need more information for medicines regulatory issues, ELS can certainly help with our registration services for your products.

Please contact your ELS local consultant or through the email: info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

I want to speak to a Specialist

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.

I want to speak to a Specialist